Hoxworth Blood Center to halt blood collections September 14 and 15 to launch new innovative donor software program
ABO QuickPass goes live September 16 to expedite registration and enhance the donor experience.
Hoxworth Blood Center, University of Cincinnati, will not be collecting blood Wednesday, September 14 and Thursday, September 15 as the blood center transitions its data to a new computer system on September 16 to better serve blood donors and hospital partners.
Hoxworth’s seven Neighborhood Donor Centers, as well as its mobile blood drive operations, will cease blood collections on those two days as a team of IT specialists from BBCS move Hoxworth’s donor data to a new computer system called ABO Suite.
BBCS, Blood Bank Computer Systems, Inc., is a dedicated partner with more than 30 years’ experience in the blood banking industry. The team of IT specialists will work to ensure a seamless transition from the previous system to the new ABO SuiteTM .
“The new ABO SuiteTM contains new features that we’re excited to introduce to our donors and hospital partners,” said Jose Cancelas, MD, PhD, Hoxworth Director and CEO. “We’re always looking for ways to enhance the donation experience and better serve hospitals and patients.”
Among the new software features is a program called ABO QuickPass, an innovative screening and registration processing platform that will allow donors to answer history and screening questions online prior to a scheduled blood donation.
Donors will be able to access the new feature from the Hoxworth website when QuickPass launches on September 16. Alternatively, donors can quickly complete the QuickPass process on site at the donation location using a tablet or workstation kiosk.
Important tips to keep in mind:
- QuickPass does not replace the task of scheduling an appointment. Donors must continue to schedule and secure an available time slot.
- The QuickPass can only be completed on the day of blood donation.
- Review all educational material presented.
- Answer the questions honestly and complete them in one timed session. If the system times out, you will need to begin anew.
- QuickPass does not determine eligibility. Eligibility will be determined at the time of donation.
- After completing the questionnaire, an option will be given to print or email a donor’s encrypted QuickPass QR code.
- Donors must bring the QuickPass QR code that contains the answers to screening questions to the Hoxworth donor center or mobile blood drive. Hoxworth personnel will be unable to access the QR code if this critical step is forgotten.
Protect Our Community Blood Supply
Meanwhile, because Hoxworth will not be collecting blood on September 14 and 15, donors are needed to help boost blood and platelet donations prior to and after the temporary closure to ensure we have a healthy supply for local patients in need. Please consider donating during these upcoming promotions.
Upcoming Promotions
- August 29 - 30: Cooler Tote at Donor Centers. Just in time for those Labor Day picnics!
- September 1: WEBN Fireworks T-shirt at Donor Centers
- September 2 - 24: Cincy Faves T-shirt at Donor Centers
- September 8 - 9: Cincy Faves T-shirt and E-card at Donor Centers. $10 whole blood, $15 red cell, $25 platelets
- September 10 - 12: Cincy Faves T-shirt and two Cincinnati Zoo tickets at Donor Centers.
- September 16: Last chance to donate blood or platelets to be eligible to win a custom MINI Cooper.
- September 16 - 24: Last chance to get the 2022 Cincy Faves Tye Dye T-Shirt at Donor Centers.
Related Stories
What's behind the mysterious rise of migraines?
January 5, 2026
Weather patterns such as extreme heat and storm conditions have been linked to migraine attacks, and research shows those environmental conditions are becoming more common. As National Geographic recently reported, one of the leading theories behind this mysterious rise is that climate change may be playing a role.
Top six 2025 nephrology drug approvals
January 5, 2026
“2025 has been a landmark year for kidney disease therapeutics, marked by a comprehensive slate of FDA approvals covering endothelin-receptor blockade, complement inhibition, GLP-1-based metabolic protection, and B-cell-directed therapy,” Prakash Gudsoorkar, MD, associate professor of clinical medicine at the University of Cincinnati College of Medicine and staff nephrologist at UC Health, recently told MedCentral.
Weight loss drugs help, but not on their own
January 5, 2026
Millions of Americans are on one type of weight loss drug or another, and a University of Cincinnati physician says there are things to know as we enter the new year. Malti Vij, MD, adjunct associate professor in the Department of Internal Medicine and provider at UC Health Primary Care in Mason, recently spoke to 91.7 WVXU News.